Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 12, 2007 - Issue 1
Submit an article Journal homepage
151
Views
11
CrossRef citations to date
0
Altmetric
Review

Emerging therapeutic options for Philadelphia-positive acute lymphocytic leukemia

Yesid Alvarado Leukemia Fellow, Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Effrosyni Apostolidou Research Postdoctoral Fellow, Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Ronan Swords Hematology Fellow, Department of Hematology, University College Hospital, Galway, Ireland
&
Francis J Giles Professor of Medicine, Section of Developmental Therapeutics, Box 428, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA. [email protected]
Pages 165-179 | Published online: 14 Mar 2007

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alexandra Böhm, Harald Herrmann, Gerlinde Mitterbauer-Hohendanner, Alexander W Hauswirth, Werner Rabitsch, Margit Mitterbauer, Wolfgang R Sperr, Peter Kalhs, Ulrich Jäger & Peter Valent. (2011) Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet ‘pre-leukemic’ stem cells?. Leukemia & Lymphoma 52:5, pages 842-848.
Read now
Wendy Stock. (2010) Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia & Lymphoma 51:2, pages 188-198.
Read now

Articles from other publishers (9)

Ilana de Fran?a Azevedo, Rui Milton Patr?cio da Silva J?nior, Audrey Violeta Martins de Vasconcelos, Washington Batista das Neves, F?rida Coeli de Barros Correia Melo & Raul Ant?nio Morais Melo. (2014) Frequency of p190 and p210 BCR-ABL rearrangements and survival in Brazilian adult patients with acute lymphoblastic leukemia. Revista Brasileira de Hematologia e Hemoterapia 36:5, pages 351-355.
Crossref
Kyung Hee ChangAbel Sanchez-AguileraShuhong ShenAmitava SenguptaMalav N. MadhuAshley M. FickerSusan K. DunnAshley M. KuenziJorden L. ArnettRebecca A. SanthoXabier AgirreJohn P. PerentesisMichael W. Deininger, Yi ZhengXose R. Bustelo, David A. WilliamsJose A. Cancelas. (2012) Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival. Blood 120:4, pages 800-811.
Crossref
Amitava Sengupta, Ashley M. FickerSusan K. Dunn, Malav MadhuJose A. Cancelas. (2012) Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL–initiating cells. Blood 119:2, pages 494-502.
Crossref
Nidal BoulosHeather L. MulderChristopher R. CalabreseJeffrey B. MorrisonJerold E. RehgMary V. Relling, Charles J. Sherr & Richard T. Williams. (2011) Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome–positive acute lymphoblastic leukemia. Blood 117:13, pages 3585-3595.
Crossref
J. Lazic, N. Tosic, L. Dokmanovic, N. Krstovski, P. Rodic, S. Pavlovic & D. Janic. (2009) Clinical features of the most common fusion genes in childhood acute lymphoblastic leukemia. Medical Oncology 27:2, pages 449-453.
Crossref
David M. Lucas, Ryan B. Edwards, Gerard LozanskiDerek A. West, Jungook D. Shin, Melissa A. Vargo, Melanie E. Davis, Darlene M. Rozewski, Amy J. Johnson, Bao-Ning Su, Virginia M. Goettl, Nyla A. HeeremaThomas S. Lin, Amy Lehman, Xiaoli Zhang, David Jarjoura, David J. Newman, John C. Byrd, A. Douglas Kinghorn & Michael R. Grever. (2009) The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood 113:19, pages 4656-4666.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref
Richard T. Williams, Willem den Besten & Charles J. Sherr. (2007) Cytokine-dependent imatinib resistance in mouse BCR-ABL + , Arf -null lymphoblastic leukemia . Genes & Development 21:18, pages 2283-2287.
Crossref
Peter H. Wiernik. (2007) Leukemias and plasma cell dyscrasias. Update on Cancer Therapeutics 2:2, pages 73-99.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.